Stock analysis, AI verdict, fundamentals & technical signals
Rating: SELL
Price: $465.45 Analyst target: $397.32 Upside: -14.64%
Amgen Inc. (formerly Applied Molecular Genetics Inc.) is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. Focused on molecular biology and biochemistry, its goal is to provide a healthcare business based on recombinant DNA technology.
See the full interactive analysis & chart →Informational only — not investment advice.